US 11999777
Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies
granted A61KA61K2039/507A61K2039/54
Quick answer
US patent 11999777 (Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 68
- CPC classes
- A61K, A61K2039/507, A61K2039/54, A61K31/706, A61K39/215